Clinical Trial Update: Renal Effects of Hormones/Biomarkers in Transgender PrEP Recipients [Phase 4]

View source ↗

Summary

Phase 4 trial examining renal effects of hormones and biomarkers in transgender individuals receiving PrEP, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Function Impairment
• Transgender Health

Snippet

Sponsor: University of California, San Diego | Conditions: Transgender, Renal Function | Phase 4 | Status: COMPLETED